Arrhythmia Recurrence After Atrial Fibrillation Ablation: Impact of Warfarin vs. Non-Vitamin K Antagonist Oral Anticoagulants.
Songnan WenCristina PislaruKristi H MonahanStephanie M BarnesDavid O HodgeDouglas L PackerSorin V PislaruSamuel J AsirvathamPublished in: Cardiovascular drugs and therapy (2021)
In this large contemporary cohort, overall AF recurrence after ablation was similar with NOACs or warfarin use. However, in patients with persistent AF, NOACs use was associated with a higher probability of arrhythmia recurrence and was an independent risk factor of recurrence at long-term follow-up.